The neurotrophin NT4/5, but not NT3, enhances the efficacy of nigral grafts in a rat model of Parkinson's disease
- 2 March 1996
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 712 (1) , 45-52
- https://doi.org/10.1016/0006-8993(95)01427-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Neurotrophic‐4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched culturesJournal of Neuroscience Research, 1994
- Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalonJournal of Neuroscience, 1994
- Neurotrophic factors and neural grafts: a growing fieldSeminars in Neuroscience, 1993
- Better cells for brain repairNature, 1993
- Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transectionNeuroscience, 1993
- Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesionsNeuroReport, 1993
- Neurotrophin-5: A novel neurotrophic factor that activates trk and trkBNeuron, 1991
- The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia [published erratum appears in J Neurosci 1992 Mar;12(3):685]Journal of Neuroscience, 1991
- Chapter 1 Grafting genetically modified cells to the brain: conceptual and technical issuesPublished by Elsevier ,1990
- Estimation of nuclear population from microtome sectionsThe Anatomical Record, 1946